tiprankstipranks
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Financial Statements

307 Followers

Pyxis Oncology Financial Overview

Pyxis Oncology's market cap is currently ―. The company's EPS TTM is $-1.383; its P/E ratio is -2.51; Pyxis Oncology is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 16.15M$ 562.00K$ 600.00K$ 600.00K$ 38.00K
Gross Profit$ 15.67M$ 562.00K$ 600.00K$ 600.00K$ 38.00K
EBIT$ -5.61M$ -17.77M$ -23.07M$ -16.65M$ -18.55M
EBITDA$ -4.49M$ -17.08M$ -24.02M$ -17.38M$ -18.96M
Net Income Common Stockholders$ -3.26M$ -15.60M$ -23.07M$ -15.90M$ -18.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 157.03M$ 119.30M$ 132.97M$ 144.13M$ 150.82M
Total Assets$ 220.22M$ 173.73M$ 186.69M$ 175.23M$ 182.80M
Total Debt$ 20.78M$ 21.33M$ 21.62M$ 21.26M$ 20.25M
Net Debt$ -136.25M$ -97.97M$ -111.35M$ -122.88M$ -130.57M
Total Liabilities$ 36.06M$ 48.02M$ 48.75M$ 29.95M$ 30.64M
Stockholders Equity$ 184.14M$ 125.70M$ 137.95M$ 145.28M$ 152.16M
Cash Flow-
Free Cash Flow$ -20.95M$ -15.25M$ -17.64M$ -13.29M$ -31.25M
Operating Cash Flow$ -20.71M$ -15.25M$ -17.58M$ -11.03M$ -26.84M
Investing Cash Flow$ -18.50M$ 10.23M$ 6.57M$ -22.25M$ -99.39M
Financing Cash Flow$ 57.51M$ -25.00K$ -171.00K$ 6.13M-
Currency in USD

Pyxis Oncology Earnings and Revenue History

Pyxis Oncology Debt to Assets

Pyxis Oncology Cash Flow

Pyxis Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis